Redo-TAVI feasibility and coronary accessibility following index TAVI with the Evolut valve in patients with bicuspid aortic valve stenosis
EuroIntervention
.
2024 Nov 18;20(22):1416-1418.
doi: 10.4244/EIJ-D-24-00702.
Authors
Ketina Arslani
1
2
,
Gabriela Tirado-Conte
1
3
,
Nicolas M Van Mieghem
4
,
Darren Mylotte
5
,
Gilbert H L Tang
6
,
Vinayak N Bapat
7
,
Lionel Leroux
8
,
Didier Tchétché
9
,
Kendra J Grubb
10
,
Ole De Backer
1
Affiliations
1
Rigshospitalet, Copenhagen, Denmark.
2
University Hospital Basel, Basel, Switzerland.
3
University Hospital Ramon y Cajal, Madrid, Spain.
4
Erasmus Medical Center, Rotterdam, the Netherlands.
5
Galway University Hospital, Galway, Ireland.
6
Mount Sinai Health System, New York, NY, USA.
7
Minneapolis Heart Institute, Minneapolis, MN, USA.
8
Centre Hospitalier Universitaire de Bordeaux, Bordeaux, France.
9
Clinique Pasteur, Toulouse, France.
10
Emory University Hospital, Atlanta, GA, USA.
PMID:
39552485
PMCID:
PMC11556401
(available on
2025-11-18
)
DOI:
10.4244/EIJ-D-24-00702
No abstract available